Organon Pharma Indonesia Tbk PT
IDX:SCPI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Organon Pharma Indonesia Tbk PT
Selling, General & Administrative
Organon Pharma Indonesia Tbk PT
Selling, General & Administrative Peer Comparison
Organon Pharma Indonesia Tbk PT
Glance View
PT Organon Pharma Indonesia Tbk engages in the development, manufacture, and distribution of pharmaceutical products. The company is headquartered in Jakarta Pusat, Dki Jakarta. The firm is engaged in the processing, packaging and development of pharmaceutical products for human and animal consumption, toiletries, cosmetics, household and related products. The firm is also engaged in importing of raw materials, finished goods and providing business and management consultancy services. The Company’s segments include Pharmaceutical Manufacturing and commercial. For women's health, the Company develops product specifically for women, including contraception, fertility, pregnancy management, perinatal diseases and other diseases. The Company’s subsidiaries include Organon LLC, PT Merck Sharp & Dohme Indonesia, Merck Sharp & Dohme Corp and Merck Sharp & Dohme Asia.
See Also
What is Organon Pharma Indonesia Tbk PT's Selling, General & Administrative?
Selling, General & Administrative
-65.1B
IDR
Based on the financial report for Dec 31, 2025, Organon Pharma Indonesia Tbk PT's Selling, General & Administrative amounts to -65.1B IDR.
What is Organon Pharma Indonesia Tbk PT's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
8%
Over the last year, the Selling, General & Administrative growth was -2%. The average annual Selling, General & Administrative growth rates for Organon Pharma Indonesia Tbk PT have been -14% over the past three years , 16% over the past five years , and 8% over the past ten years .
